Skip to main content
$6.28 -0.26 (-3.91%)
Market Cap
$80.87M
Shares
12.38M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$3.57M +32.9%
FY2025 Revenue FY2022–FY2025
Net Income
-$7.8M +5.4%
FY2025 Net Income FY2022–FY2025
Gross Margin
84.23% -2.3pp
FY2025 Gross Margin FY2022–FY2025
Operating Margin
-219.37% +47.1pp
FY2025 Operating Margin FY2022–FY2025
Diluted EPS
-$0.95 +22.1%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
-$6.43M -5.5%
FY2025 Operating Cash Flow FY2022–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022
$4.28M $3.57M $2.69M $2.46M $2.68M
$641.81K $562.92K $362K $303.35K $297.06K
$3.64M $3.01M $2.32M $2.16M $2.39M
84.23% 86.52% 87.67% 88.94%
$475.31K $493.61K $433.61K $169.32K $225.61K
$7.84M $8.06M $7.58M $8.33M $5.12M
$21.81K $11.49K $10.49K $6213
$69.46K $59.5K $37.83K $40.73K $37.13K
-$7.28M -$7.83M -$7.16M -$6.66M -$3.37M
-219.37% -266.46% -270.91% -125.61%
-$7.21M -$7.77M -$7.12M -$6.62M -$3.34M
$97.92K $73.97K $174.33K $476.42K $318.67K
-$7814 $29.35K -$1.08M -$7.96M -$1.41M
-$7.28M -$7.8M -$8.24M -$14.63M -$4.78M
-218.55% -306.84% -594.57% -178.05%
-$8.07M -$8.62M -$8.45M -$14.63M -$5.54M
USD/shares -$0.95 -$1.22 -$4.50 -$2.77
USD/shares -$0.95 -$1.22 -$4.50 -$2.77
shares 9.08M 6.92M 3.25M 2M
shares 9.08M 6.92M 3.25M 2M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Peer median 4.16×
EV/EBIT
Peer median 27.19×
P/E (TTM)
Peer median 2.11×

Peer medians compare against the 297 similar-size Biotechnology companies (of 522 listed).

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022
All Other States $1,245,322 $767,993 $726,478 $699,125
CA $898,223 $778,209 $601,235 $408,645
OH $578,769 $431,328 $407,632 $500,260
MA $265,201 $154,407 $127,300
IL $222,389 $246,217 $117,963
WI $215,431 $157,786 $292,601 $670,245
FL $143,947 $149,985 $186,840 $231,480
Macao SAR China $174,980
Key facts CIK 1933567 CUSIP 64134X201 13F (30d) 3 filings 3 filers Visit website Investor relations